What is "lefamulin"

Lefamulin is a pleuromutilin antibiotic that is being developed by Nabriva Therapeutics for the treatment of acute bacterial skin and skin-structure infections (ABSSSI). It was granted fast track status by the US Food and Drug Administration in 2014. , it is in phase III clinical trials.